Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus rivaroxaban for venous thromboembolism prophylaxis after total joint arthroplasty
ChiCTR1800020289Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in venous thromboembolism (VTE) comparing Aspirin arm with Rivaroxaban arm (2 arms). Primary endpoints: prothrombin time, activated partial thromboplastin time and 13 more. Started Jan 2019; status: recruiting.
02
Drugs
aspirinrivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR1800020289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020289.